Contact.
We read every message before approving any pilot.

For pharma medical affairs, R&D, academic pathology, or clinical advisory — email the founder directly, or leave a note via the early-access form below. Replies within five working days.

Founder:
kaustubh@hueclinical.com

Company:
Hue Clinical Pvt. Ltd.
Bengaluru, India

We do not have a phone line during the pre-launch sprint. Email is the fastest path to the founder.

Join the early-access list.
We'll write back personally.

For pharma medical affairs, R&D, and academic pathology — leave an email and a short note. Hue is pre-launch; we read every message before approving any pilot.

WE WILL NEVER ADD YOU TO A MAILING LIST · WORK EMAIL PREFERRED
PHARMA
Cohort identification, access programs, R&D collaboration.
LABS · PATHOLOGISTS
Reading-system pilots inside existing LIS workflows.
ACADEMIC · ADVISORY
Validation co-authorship, clinical advisory board.